Haemonetics (HAE) Change in Accured Expenses (2009 - 2026)

Haemonetics has reported Change in Accured Expenses for 18 years, with the latest figure at $20.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 15.41% year-over-year to $20.3 million; the trailing twelve-month figure through Mar 2026 stood at -$16.6 million (up 13.73% YoY), and the FY2026 full-year result was -$16.6 million, up 13.73% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $20.3 million, up from -$6.7 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $49.5 million in Q1 2024, with the low at -$47.9 million in Q2 2025.
• Average Change in Accured Expenses over 5 years is $4.5 million, with a median of $6.7 million recorded in 2022.
• Year-over-year, Change in Accured Expenses surged 836.31% in 2022 and sank 424.4% in 2023.
• Tracing HAE's Change in Accured Expenses over 5 years: stood at $7.3 million in 2022, then slumped by 424.4% to -$23.7 million in 2023, then jumped by 113.96% to $3.3 million in 2024, then tumbled by 302.36% to -$6.7 million in 2025, then surged by 403.49% to $20.3 million in 2026.
• The last three Change in Accured Expenses figures came in at $20.3 million (Q1 2026), -$6.7 million (Q4 2025), and $17.7 million (Q3 2025), per Business Quant data.

Peer Comparison